Anchalee Phanmaha/Getty Images
Sponsor Message
Get the latest on need-to-know topics for federal employees delivered to your inbox.
Register for Newsletter
A new Medicare program launching July 1 broadens access to drugs like Zepbound and Foundayo, but federal annuitants need to know how the $50 copay will affect their catastrophic limits.
Anchalee Phanmaha/Getty Images
Sponsor Message
Get the latest on need-to-know topics for federal employees delivered to your inbox.
Register for Newsletter

The Oral GLP-1 Tracker: Wegovy pill total scripts down for first time

FDA floats possible approach to repurpose approved drugs under new uses

Why big digital health players are missing from Medicare's chronic care experiment

Amgen expands crackdown on what it says is misuse of 340B program

Five steps to make commercial-first government work

Medicare is spending far less than expected on new Alzheimer’s drugs